scholarly journals Decision Support System for the Assessment of Risk Factors for Type 2 Diabetes and Minimizing the Risk for Complications

2015 ◽  
Vol 122 (1) ◽  
pp. 1-5
Author(s):  
Soumaya Fellaji ◽  
Abdellah Azmani ◽  
Abdelhadi Akharif
Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 952-P
Author(s):  
ANGELA LIBISELLER ◽  
KATHARINA M. LICHTENEGGER ◽  
JULIA KOPANZ ◽  
ANTONELLA DE CAMPO ◽  
TATJANA WIESINGER ◽  
...  

2015 ◽  
Vol 23 (6) ◽  
pp. 336 ◽  
Author(s):  
Mehdi Rasoolimoghadam ◽  
Reza Safdari ◽  
Marjan Ghazisaeidi ◽  
MohammadReza Maharanitehrani ◽  
Shahram Tahmasebiyan

2020 ◽  
pp. 193229682095524
Author(s):  
Katharina M. Lichtenegger ◽  
Felix Aberer ◽  
Alexandru C. Tuca ◽  
Klaus Donsa ◽  
Bernhard Höll ◽  
...  

The aim was to investigate the applicability of a clinical decision support system in a real-world inpatient setting for patients with type 2 diabetes on general hospital wards. A total of 150 patients with type 2 diabetes requiring subcutaneous insulin therapy were treated with basal-bolus insulin therapy guided by a decision support system (GlucoTab) providing automated workflow tasks and suggestions for insulin dosing to health care professionals. By using the system, a mean daily blood glucose (BG) of 159 ± 32 mg/dL was achieved. 68.8% of measurements were in the target range (70 to <180 mg/dL). The percentage of BG values <40, <70, and ≥300 mg/dL was 0.02%, 2.2%, and 2.3%, respectively. Health care professionals’ adherence to suggested insulin doses and workflow tasks was high (>93% and 91%, respectively). The decision support system facilitates safe and efficacious inpatient diabetes care by standardizing treatment workflow and providing decision support for basal-bolus insulin dosing.


Sign in / Sign up

Export Citation Format

Share Document